于向溟YU XIANGMING 于向溟YUXIANGMING
于向溟YUXIANGMING于向溟YUXIANGMING
DegronTherapeuticsaimstobecomeagloballeaderinthediscoveryanddevelopmentofanewclassoftargetedproteindegradationtherapeutics,smallmoleculemoleculargluedegrader(MGD)drugs.Degronhasassembledateamofworld-classexecutivesandscientificleaders,bringingitsscientificexcellencetotheidentificationandvalidationofdiseasetargets,particularlythoseundruggablebyconventionalsmallmoleculeinhibitors,andnovelselectiveMGDcompoundstomeetunmetmedicalneedsinalltherapeuticareas.